CN101780181A - 一氧化氮自由基保健品 - Google Patents
一氧化氮自由基保健品 Download PDFInfo
- Publication number
- CN101780181A CN101780181A CN200910013947A CN200910013947A CN101780181A CN 101780181 A CN101780181 A CN 101780181A CN 200910013947 A CN200910013947 A CN 200910013947A CN 200910013947 A CN200910013947 A CN 200910013947A CN 101780181 A CN101780181 A CN 101780181A
- Authority
- CN
- China
- Prior art keywords
- milligrams
- health care
- free radical
- nitric oxide
- oxide free
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 Nitric oxide free radical Chemical class 0.000 title claims abstract description 33
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title claims abstract description 32
- 239000000284 extract Substances 0.000 claims abstract description 44
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims abstract description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 8
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 8
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000012754 curcumin Nutrition 0.000 claims abstract description 7
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 7
- 239000011669 selenium Substances 0.000 claims abstract description 7
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims abstract description 5
- 229930064664 L-arginine Natural products 0.000 claims abstract description 5
- 235000014852 L-arginine Nutrition 0.000 claims abstract description 5
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229960002173 citrulline Drugs 0.000 claims abstract description 5
- 229960000304 folic acid Drugs 0.000 claims abstract description 5
- 235000019152 folic acid Nutrition 0.000 claims abstract description 5
- 239000011724 folic acid Substances 0.000 claims abstract description 5
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 4
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 4
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims abstract description 4
- 235000013734 beta-carotene Nutrition 0.000 claims abstract description 4
- 239000011648 beta-carotene Substances 0.000 claims abstract description 4
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims abstract description 4
- 229960002747 betacarotene Drugs 0.000 claims abstract description 4
- KVUAALJSMIVURS-ZEDZUCNESA-L calcium folinate Chemical compound [Ca+2].C1NC=2NC(N)=NC(=O)C=2N(C=O)C1CNC1=CC=C(C(=O)N[C@@H](CCC([O-])=O)C([O-])=O)C=C1 KVUAALJSMIVURS-ZEDZUCNESA-L 0.000 claims abstract description 4
- 235000008207 calcium folinate Nutrition 0.000 claims abstract description 4
- 239000011687 calcium folinate Substances 0.000 claims abstract description 4
- 229920002770 condensed tannin Polymers 0.000 claims abstract description 4
- 239000004148 curcumin Substances 0.000 claims abstract description 4
- 229940109262 curcumin Drugs 0.000 claims abstract description 4
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims abstract description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000018192 pine bark supplement Nutrition 0.000 claims abstract description 4
- 229940106796 pycnogenol Drugs 0.000 claims abstract description 4
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 4
- 229940046009 vitamin E Drugs 0.000 claims abstract description 4
- 239000011709 vitamin E Substances 0.000 claims abstract description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims abstract description 4
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims description 10
- 244000068988 Glycine max Species 0.000 claims description 9
- 235000010469 Glycine max Nutrition 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 235000019136 lipoic acid Nutrition 0.000 claims description 6
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical class OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 6
- 229930182490 saponin Natural products 0.000 claims description 6
- 150000007949 saponins Chemical class 0.000 claims description 6
- 235000017709 saponins Nutrition 0.000 claims description 6
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical class O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 claims description 5
- QSLPNSWXUQHVLP-UHFFFAOYSA-N $l^{1}-sulfanylmethane Chemical compound [S]C QSLPNSWXUQHVLP-UHFFFAOYSA-N 0.000 claims description 4
- FBHZOFXJBNZTGR-BENRWUELSA-N 2-[(z)-dodec-7-enyl]octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)CCCCCC\C=C/CCCC FBHZOFXJBNZTGR-BENRWUELSA-N 0.000 claims description 4
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 claims description 4
- 240000008384 Capsicum annuum var. annuum Species 0.000 claims description 4
- 235000009392 Vitis Nutrition 0.000 claims description 4
- 241000219095 Vitis Species 0.000 claims description 4
- 238000006356 dehydrogenation reaction Methods 0.000 claims description 4
- 206010012601 diabetes mellitus Diseases 0.000 claims description 4
- 230000002526 effect on cardiovascular system Effects 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- 235000012239 silicon dioxide Nutrition 0.000 claims description 4
- MTDHILKWIRSIHB-UHFFFAOYSA-N (5-azaniumyl-3,4,6-trihydroxyoxan-2-yl)methyl sulfate Chemical compound NC1C(O)OC(COS(O)(=O)=O)C(O)C1O MTDHILKWIRSIHB-UHFFFAOYSA-N 0.000 claims description 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 3
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims description 3
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 3
- 241000219357 Cactaceae Species 0.000 claims description 3
- 244000025254 Cannabis sativa Species 0.000 claims description 3
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 3
- 208000035473 Communicable disease Diseases 0.000 claims description 3
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 3
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 3
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 3
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 3
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 3
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 3
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 3
- 240000000171 Crataegus monogyna Species 0.000 claims description 3
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 3
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 3
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 3
- 206010012289 Dementia Diseases 0.000 claims description 3
- 241000222336 Ganoderma Species 0.000 claims description 3
- 235000011201 Ginkgo Nutrition 0.000 claims description 3
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims description 3
- 240000001080 Grifola frondosa Species 0.000 claims description 3
- 235000007710 Grifola frondosa Nutrition 0.000 claims description 3
- ZRJBHWIHUMBLCN-SEQYCRGISA-N Huperzine A Natural products N1C(=O)C=CC2=C1C[C@H]1/C(=C/C)[C@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-SEQYCRGISA-N 0.000 claims description 3
- 206010061218 Inflammation Diseases 0.000 claims description 3
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 3
- 240000000599 Lentinula edodes Species 0.000 claims description 3
- 235000001715 Lentinula edodes Nutrition 0.000 claims description 3
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 claims description 3
- 241000228347 Monascus <ascomycete fungus> Species 0.000 claims description 3
- 206010028980 Neoplasm Diseases 0.000 claims description 3
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 3
- ZRJBHWIHUMBLCN-UHFFFAOYSA-N Shuangyiping Natural products N1C(=O)C=CC2=C1CC1C(=CC)C2(N)CC(C)=C1 ZRJBHWIHUMBLCN-UHFFFAOYSA-N 0.000 claims description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 3
- 229940046374 chromium picolinate Drugs 0.000 claims description 3
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 claims description 3
- 239000005515 coenzyme Substances 0.000 claims description 3
- 230000003412 degenerative effect Effects 0.000 claims description 3
- 230000003001 depressive effect Effects 0.000 claims description 3
- 230000003203 everyday effect Effects 0.000 claims description 3
- 229930003944 flavone Natural products 0.000 claims description 3
- 150000002212 flavone derivatives Chemical class 0.000 claims description 3
- 235000011949 flavones Nutrition 0.000 claims description 3
- 229960002849 glucosamine sulfate Drugs 0.000 claims description 3
- ZRJBHWIHUMBLCN-YQEJDHNASA-N huperzine A Chemical compound N1C(=O)C=CC2=C1C[C@H]1\C(=C/C)[C@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-YQEJDHNASA-N 0.000 claims description 3
- 208000015181 infectious disease Diseases 0.000 claims description 3
- 230000004054 inflammatory process Effects 0.000 claims description 3
- 206010022437 insomnia Diseases 0.000 claims description 3
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 3
- 235000008696 isoflavones Nutrition 0.000 claims description 3
- 210000004185 liver Anatomy 0.000 claims description 3
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 claims description 3
- 229960004844 lovastatin Drugs 0.000 claims description 3
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 claims description 3
- AEDDIBAIWPIIBD-ZJKJAXBQSA-N mangiferin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC=2C(=CC(O)=C(O)C=2)C2=O)C2=C1O AEDDIBAIWPIIBD-ZJKJAXBQSA-N 0.000 claims description 3
- 201000008482 osteoarthritis Diseases 0.000 claims description 3
- 229940068041 phytic acid Drugs 0.000 claims description 3
- ZRJBHWIHUMBLCN-BMIGLBTASA-N rac-huperzine A Natural products N1C(=O)C=CC2=C1C[C@@H]1C(=CC)[C@@]2(N)CC(C)=C1 ZRJBHWIHUMBLCN-BMIGLBTASA-N 0.000 claims description 3
- 230000035911 sexual health Effects 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims description 3
- DJWUNCQRNNEAKC-UHFFFAOYSA-L zinc acetate Chemical class [Zn+2].CC([O-])=O.CC([O-])=O DJWUNCQRNNEAKC-UHFFFAOYSA-L 0.000 claims description 3
- 235000013904 zinc acetate Nutrition 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- 235000019764 Soybean Meal Nutrition 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- 235000002532 grape seed extract Nutrition 0.000 abstract 1
- 235000020741 pine bark extract Nutrition 0.000 abstract 1
- 229940106587 pine bark extract Drugs 0.000 abstract 1
- 239000004455 soybean meal Substances 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 229960001570 ademetionine Drugs 0.000 description 2
- 229960004543 anhydrous citric acid Drugs 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000005251 gamma ray Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 240000005546 Piper methysticum Species 0.000 description 1
- 235000016787 Piper methysticum Nutrition 0.000 description 1
- 239000004383 Steviol glycoside Substances 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229940065287 selenium compound Drugs 0.000 description 1
- 150000003343 selenium compounds Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 229930182488 steviol glycoside Natural products 0.000 description 1
- 235000019411 steviol glycoside Nutrition 0.000 description 1
- 150000008144 steviol glycosides Chemical class 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910013947A CN101780181A (zh) | 2009-01-16 | 2009-01-16 | 一氧化氮自由基保健品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200910013947A CN101780181A (zh) | 2009-01-16 | 2009-01-16 | 一氧化氮自由基保健品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101780181A true CN101780181A (zh) | 2010-07-21 |
Family
ID=42520405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200910013947A Pending CN101780181A (zh) | 2009-01-16 | 2009-01-16 | 一氧化氮自由基保健品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101780181A (zh) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102356879A (zh) * | 2011-10-21 | 2012-02-22 | 深圳市俪斯生物科技有限公司 | 一种功能肽强化的保健食品 |
CN102526347A (zh) * | 2012-03-14 | 2012-07-04 | 上海善力健保健食品有限公司 | 一种具有改善记忆及脑功能保健品及制作方法 |
CN102600260A (zh) * | 2010-12-24 | 2012-07-25 | 漆又毛 | 一种氨基酸和提取物组合物防治老年性痴呆的药物用途 |
CN102697044A (zh) * | 2012-06-09 | 2012-10-03 | 东莞市照燕生物科技有限公司 | 一种冠心病的营养保健品 |
CN102861180A (zh) * | 2012-09-27 | 2013-01-09 | 福州海王福药制药有限公司 | 一种能改善心脑血管疾病含有氨基酸的组合物及其应用 |
CN102885797A (zh) * | 2012-10-29 | 2013-01-23 | 福州海王福药制药有限公司 | 一种含匹伐他汀钙的组合物及其制备方法和应用 |
CN103054855A (zh) * | 2012-12-25 | 2013-04-24 | 常州亚当生物技术有限公司 | 一种组合物及其制备方法、应用 |
CN103099211A (zh) * | 2012-12-21 | 2013-05-15 | 洪万雄 | 一种融合辅酶q10的广谱性一氧化氮保健品 |
CN103263018A (zh) * | 2013-04-27 | 2013-08-28 | 北京中国科学院老专家技术中心 | 一氧化氮功能饮料及其制备方法 |
CN104026563A (zh) * | 2013-03-07 | 2014-09-10 | 山东明仁福瑞达制药股份有限公司 | 一种具有缓解体力疲劳、提高缺氧耐受力作用的组合物及其制备方法 |
ITMI20131028A1 (it) * | 2013-06-20 | 2014-12-21 | Italfarmaco Spa | Arginina e/o citrullina per uso nel trattamento e/o nella prevenzione dell'artrosi |
CN104256651A (zh) * | 2014-10-22 | 2015-01-07 | 何瑞红 | 改善男性性功能的组合物及其制备方法和应用 |
CN104366475A (zh) * | 2014-11-10 | 2015-02-25 | 罗会明 | 一种增强型保健品 |
CN104491350A (zh) * | 2014-12-27 | 2015-04-08 | 张标 | 一种调节心脑血管健康和减少心脑血管疾病风险的保健品 |
CN105079777A (zh) * | 2015-08-05 | 2015-11-25 | 山东金城生物药业有限公司 | 抗氧化、提高免疫力的组合物及其制备方法和应用 |
CN105412390A (zh) * | 2015-11-22 | 2016-03-23 | 威海百合生物技术股份有限公司 | 一种调节气血保健软胶囊 |
CN105878282A (zh) * | 2016-05-14 | 2016-08-24 | 张恒洲 | 一种以牛黄和一氧化氮配伍的保健品及其制备方法 |
CN106307547A (zh) * | 2016-08-24 | 2017-01-11 | 徐金蝶 | 一种含大蒜素的降脂保健片及其制备方法 |
CN106999533A (zh) * | 2014-12-23 | 2017-08-01 | 生创康有限公司 | 抗微生物组合物 |
CN110693885A (zh) * | 2018-07-09 | 2020-01-17 | 成都百裕制药股份有限公司 | 预防或治疗性功能障碍的药物组合物及其用途 |
WO2020115274A1 (en) * | 2018-12-07 | 2020-06-11 | Inxo Ivs | Compositions for improving sexual function |
CN113116898A (zh) * | 2021-04-20 | 2021-07-16 | 北京天玺宝科技有限公司 | 一种具有减肥功能的包含左卡尼汀或乙酰左卡尼汀和育亨宾的组合物及其应用 |
IT202100020216A1 (it) * | 2021-07-28 | 2023-01-28 | Neilos S R L | “Composizione nutraceutica o farmaceutica comprendente un estratto di Silybum marianum per l’uso nel trattamento e/o nella prevenzione di condizioni o patologie epato-biliari” |
US11571405B2 (en) | 2018-12-07 | 2023-02-07 | Inxo A/S | Compositions for improving sexual function |
-
2009
- 2009-01-16 CN CN200910013947A patent/CN101780181A/zh active Pending
Cited By (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102600260A (zh) * | 2010-12-24 | 2012-07-25 | 漆又毛 | 一种氨基酸和提取物组合物防治老年性痴呆的药物用途 |
CN102356879B (zh) * | 2011-10-21 | 2014-08-06 | 深圳市俪斯生物科技有限公司 | 一种功能肽强化的保健食品 |
CN102356879A (zh) * | 2011-10-21 | 2012-02-22 | 深圳市俪斯生物科技有限公司 | 一种功能肽强化的保健食品 |
CN102526347A (zh) * | 2012-03-14 | 2012-07-04 | 上海善力健保健食品有限公司 | 一种具有改善记忆及脑功能保健品及制作方法 |
CN102526347B (zh) * | 2012-03-14 | 2014-12-17 | 上海善力健保健食品有限公司 | 一种具有改善记忆及脑功能保健品及制作方法 |
CN102697044A (zh) * | 2012-06-09 | 2012-10-03 | 东莞市照燕生物科技有限公司 | 一种冠心病的营养保健品 |
CN102861180A (zh) * | 2012-09-27 | 2013-01-09 | 福州海王福药制药有限公司 | 一种能改善心脑血管疾病含有氨基酸的组合物及其应用 |
CN102885797A (zh) * | 2012-10-29 | 2013-01-23 | 福州海王福药制药有限公司 | 一种含匹伐他汀钙的组合物及其制备方法和应用 |
CN103099211A (zh) * | 2012-12-21 | 2013-05-15 | 洪万雄 | 一种融合辅酶q10的广谱性一氧化氮保健品 |
CN103054855B (zh) * | 2012-12-25 | 2014-03-26 | 常州亚当生物技术有限公司 | 一种组合物及其制备方法、应用 |
CN103054855A (zh) * | 2012-12-25 | 2013-04-24 | 常州亚当生物技术有限公司 | 一种组合物及其制备方法、应用 |
CN104026563A (zh) * | 2013-03-07 | 2014-09-10 | 山东明仁福瑞达制药股份有限公司 | 一种具有缓解体力疲劳、提高缺氧耐受力作用的组合物及其制备方法 |
CN103263018A (zh) * | 2013-04-27 | 2013-08-28 | 北京中国科学院老专家技术中心 | 一氧化氮功能饮料及其制备方法 |
WO2014203200A1 (en) | 2013-06-20 | 2014-12-24 | Italfarmaco Spa | Arginine and/or citrulline for use in the treatment and/or prevention of osteoarthritis |
ITMI20131028A1 (it) * | 2013-06-20 | 2014-12-21 | Italfarmaco Spa | Arginina e/o citrullina per uso nel trattamento e/o nella prevenzione dell'artrosi |
EA030755B1 (ru) * | 2013-06-20 | 2018-09-28 | Италфармако Спа | Применение аргинина для лечения и/или профилактики остеоартроза |
CN104256651A (zh) * | 2014-10-22 | 2015-01-07 | 何瑞红 | 改善男性性功能的组合物及其制备方法和应用 |
CN104366475A (zh) * | 2014-11-10 | 2015-02-25 | 罗会明 | 一种增强型保健品 |
CN104366475B (zh) * | 2014-11-10 | 2016-01-20 | 罗会明 | 一种增强型保健品 |
CN106999533A (zh) * | 2014-12-23 | 2017-08-01 | 生创康有限公司 | 抗微生物组合物 |
CN104491350A (zh) * | 2014-12-27 | 2015-04-08 | 张标 | 一种调节心脑血管健康和减少心脑血管疾病风险的保健品 |
CN104491350B (zh) * | 2014-12-27 | 2017-11-07 | 上海诺鼎生物科技有限公司 | 一种调节心脑血管健康和减少心脑血管疾病风险的保健品 |
CN105079777A (zh) * | 2015-08-05 | 2015-11-25 | 山东金城生物药业有限公司 | 抗氧化、提高免疫力的组合物及其制备方法和应用 |
CN105079777B (zh) * | 2015-08-05 | 2017-12-26 | 山东金城生物药业有限公司 | 抗氧化、提高免疫力的组合物及其制备方法和应用 |
CN105412390A (zh) * | 2015-11-22 | 2016-03-23 | 威海百合生物技术股份有限公司 | 一种调节气血保健软胶囊 |
CN105878282A (zh) * | 2016-05-14 | 2016-08-24 | 张恒洲 | 一种以牛黄和一氧化氮配伍的保健品及其制备方法 |
CN106307547A (zh) * | 2016-08-24 | 2017-01-11 | 徐金蝶 | 一种含大蒜素的降脂保健片及其制备方法 |
CN110693885A (zh) * | 2018-07-09 | 2020-01-17 | 成都百裕制药股份有限公司 | 预防或治疗性功能障碍的药物组合物及其用途 |
US10993924B2 (en) | 2018-12-07 | 2021-05-04 | Inxo A/S | Compositions for improving sexual function |
WO2020115274A1 (en) * | 2018-12-07 | 2020-06-11 | Inxo Ivs | Compositions for improving sexual function |
CN113645965A (zh) * | 2018-12-07 | 2021-11-12 | Inxo公司 | 用于改善性机能的组合物 |
US11304920B2 (en) | 2018-12-07 | 2022-04-19 | Inxo A/S | Compositions for improving sexual function |
US11571405B2 (en) | 2018-12-07 | 2023-02-07 | Inxo A/S | Compositions for improving sexual function |
CN115919828A (zh) * | 2018-12-07 | 2023-04-07 | Inxo公司 | 用于改善性机能的组合物 |
JP7459099B2 (ja) | 2018-12-07 | 2024-04-01 | インクソ エー/エス | 性機能を改善するための組成物 |
CN113116898A (zh) * | 2021-04-20 | 2021-07-16 | 北京天玺宝科技有限公司 | 一种具有减肥功能的包含左卡尼汀或乙酰左卡尼汀和育亨宾的组合物及其应用 |
IT202100020216A1 (it) * | 2021-07-28 | 2023-01-28 | Neilos S R L | “Composizione nutraceutica o farmaceutica comprendente un estratto di Silybum marianum per l’uso nel trattamento e/o nella prevenzione di condizioni o patologie epato-biliari” |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101780181A (zh) | 一氧化氮自由基保健品 | |
US20050266018A1 (en) | Nutraceutical compositions with mangosteen | |
US20040076641A1 (en) | Herbal dietary supplement | |
US6805866B2 (en) | Oral supplement composition containing a plurality of mushroom strains | |
KR20140004976A (ko) | 생약제를 주재로 한 환의 제조방법 | |
CN102861180A (zh) | 一种能改善心脑血管疾病含有氨基酸的组合物及其应用 | |
CN101856384B (zh) | 一种护肝组合物 | |
KR101578070B1 (ko) | 발모 촉진, 탈모 완화 및 개선, 혈당 조절, 위장 장애 증상 완화 및 개선용 건강보조식품 | |
US20080152733A1 (en) | Noni juice composition | |
CN101455392B (zh) | 一种能延缓衰老的营养保健品及其制备方法 | |
Sandhu et al. | Caries protective foods: a futurist perspective | |
CN102613648B (zh) | 一种原生态竹锗营养液的制备方法 | |
CN103156255A (zh) | 健心脑耳肽保健食品和饮品系列产品及其制作方法 | |
KR101992174B1 (ko) | 복합 한방약초를 포함하는 숙취 예방, 숙취 해소 및 간 보호용 정제형 조성물 및 그 제조방법 | |
Babar et al. | Therapeutic Effect of Moringa Oleifera: A Review | |
Algethami et al. | Bee pollen: Clinical trials and patent applications. Nutrients. 2022, 14, 2858 | |
WO2016009021A1 (de) | Verabreichungsform enthaltend pilzkomponenten | |
RU2489039C2 (ru) | Биологически активная добавка к пище тонизирующего и адаптогенного действия | |
RU2321275C2 (ru) | Композиция растительных ингредиентов, обладающая геропротективными свойствами (варианты) | |
RU2376887C1 (ru) | Биологически активная добавка к пище | |
Osifo et al. | A murine model study on the effect of Garcinia kola on body weight | |
JP2003026593A (ja) | 強力な抗酸化作用を有する生薬処方 | |
KR20060129630A (ko) | 피부미용에 탁월한 건강보조식품 | |
Kerna et al. | J, Pruitt KD, Flores JV, Ortigas MAC, Carsrud NDV, Holets HM, Nomel R, Nwokorie U, Nwachukwu D.“Star Anise: A Purported Antiviral Herb with Numerous Associated Health Benefits” | |
Tufail et al. | Garden cress seeds: a review on nutritional composition, therapeutic potential, and industrial utilization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: XIAMEN BAYLOR BIO-TECH. CO., LTD. Free format text: FORMER OWNER: CHEN XIANGHUAI Effective date: 20111231 Owner name: CHEN XIANGHUAI Effective date: 20111231 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 361000 XIAMEN, FUJIAN PROVINCE TO: 361010 XIAMEN, FUJIAN PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20111231 Address after: 361010, Fujian City, Xiamen province Huli District venture Road No. 1 Pioneer Park building 701 Applicant after: Xiamen Yue Yuan Biotechnology Co., Ltd. Co-applicant after: Chen Xianghuai Address before: 361000 room 355, Nanshan Road, Huli District, Fujian, Xiamen, 703 Applicant before: Chen Xianghuai |
|
ASS | Succession or assignment of patent right |
Owner name: CHEN XIANGHUAI Free format text: FORMER OWNER: XIAMEN BAYLOR BIO-TECH. CO., LTD. Effective date: 20121015 Free format text: FORMER OWNER: CHEN XIANGHUAI Effective date: 20121015 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 361010 XIAMEN, FUJIAN PROVINCE TO: 361006 XIAMEN, FUJIAN PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20121015 Address after: 361006 room 355, Nanshan Road, Huli District, Fujian, Xiamen, 703 Applicant after: Chen Xianghuai Address before: 361010, Fujian City, Xiamen province Huli District venture Road No. 1 Pioneer Park building 701 Applicant before: Xiamen Yue Yuan Biotechnology Co., Ltd. Applicant before: Chen Xianghuai |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20100721 |